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Thermoreversible gels which transition between liquid-like and solid-like states when warmed 
have enabled significant novel healthcare technologies. Poly(N,N-diethyl acrylamide) (PDEA) 
is a thermoresponsive polymer which could be used as a trigger to form thermoreversible gels, 
however its use in these materials is limited and crucial design principles are unknown. Herein 
copolymers with the structure PDEA-b-poly(ethylene glycol) (PEG)-b-PDEA were 
synthesized to give four block copolymers with varied molecular weight of PDEA and PEG 
blocks. Rheometry on solutions of the block copolymers revealed that high molecular weight 
PEG blocks were required to form thermoreversible gels with predominantly solid-like 
behaviour. Furthermore, small-angle X-ray scattering elucidated clear differences in the 
nanostructure of the copolymer library which can be linked to distinct rheological behaviours. 
A thermoreversible gel formulation based on PDEA (20 kDa)-b-PEG (10 kDa)-b-PDEA (20 
kDa) was designed by optimising the polymer concentration and ionic strength. It was found 
that the gel was mucoadhesive, stable and non-toxic, as well as giving controlled release of a 
hydrophobic drug. Overall, this study provides insight into the effect of polymer architecture 
on the nanostructure and rheology of PDEA-b-PEG-b-PDEA and presents the development of 
a highly functional thermoreversible gel with high promise for healthcare applications. 
 




Thermoreversible gels may switch their state from a low viscosity solution to a gel dependent 
upon temperature. Engineering these materials so that the sol-gel transition occurs upon 
warming may be achieved by exploiting polymers with lower critical solution temperatures 
(LCSTs).[1,2] This phenomenon manifests as a solvophilicity when T<LCST but a relative 
solvophobicity when T>LCST, which in homopolymers is typically accompanied by a coil-to-
globule transition and higher order mesoglobular states.[3,4] Thermoreversible gels may be 
achieved in these systems when the polymer exhibiting an LCST is covalently bonded to a 
polymer chain exhibiting solvophilicity over all temperature investigated such that the LCST 




entanglements to form a percolating gel phase.[1] The triggering of this gel phase by gentle 
heating presents opportunity in applications such as drug delivery,[2] bioprinting[5] and tissue 
engineering,[6] particularly where this transition (Tgel) occurs between 25 and ca 37 °C such 
that in situ gel formation is achieved with exposure to the body’s heat. 
One thermoresponsive polymer is poly(N,N-diethyl acrylamide) (PDEA)[7] which exhibits an 
LCST of ca. 33 °C,[8] and as such is attractive to design thermoreversible gels with in situ 
gelation potential. However, unlike the structurally-related poly(N-isopropyl acrylamide) 
(PNIPAM),[9] studies of PDEA are limited.[8] PDEA exhibits relative insensitivity to 
concentration, with the LCST dropping from 34 to 32 °C when concentration is increased from 
0.5 to 4 wt%, which stabilises at 32 °C at concentrations above this.[8] The LCST may be further 
manipulated by additives, rising by up to ca. 3 °C with the addition of sodium dodecyl sulfate 
and reducing by up to ca. 20 °C with the addition of sodium chloride due to the electrolyte’s 
“salting-out” effect.[8] PDEA also exhibits a dependency of the LCST with molecular weight, 
with minor (<2 °C) suppression of cloud points with increasing Mw.
[10] This ability to make 
precision manipulation to the LCST further supports PDEA as a functional material for 
thermoreversible gel design, however it remains underexploited and unoptimised. To the 
authors’ knowledge, only a single thermoreversible gel using PDEA is reported, a PDEA-
poly(acrylic acid)-PDEA copolymer which formed gels at concentrations as low as 3 wt%, far 
lower than the widely-used Poloxamer 407 gels.[11,12] However, these materials had the 
disadvantage that Tgel occurred at 60 °C and are therefore not of relevance for many biomedical 
applications. Poly(ethylene glycol) (PEG)-b-PDEA materials have been prepared[13] which are 
capable of self-assembling upon increase in temperature, but no gelation was reported. It was 
hypothesised that PDEA-b-PEG-b-PDEA systems would be capable of undergoing 
thermoreversible gelation due to the ability of triblock copolymers to form flower-like micelles, 
which may then be bridged by the unimer chain to drive gel phase formation, as observed for 
PNIPAM-b-PEG-b-PNIPAM.[14,15] 
Within this study, the thermoreversible gelation of aqueous PDEA-b-PEG-b-PDEA solutions 
was explored as a function of molecular weight, varying PDEA Mn from ca 10 to 20 kDa and 
PEG from ca 5 to 10 kDa, using small-angle X-ray scattering (SAXS) to elucidate the 
morphology of the aggregates present in solution. These thermoreversible gels were then 
optimised with respect to Tgel and gel strength by manipulation of architecture, polymer 




applications in healthcare. This material was then explored for topical drug delivery of both 
hydrophilic and hydrophobic molecules. 
 
2. Materials and methods 
2.1 Materials 
N,N-diethyl acrylamide (DEA) (99 %) and progesterone (99 %) were purchased from Sigma-
Aldrich (U.K.). Tris[2-(dimethylamino)ethyl]amine (Me6TREN) (99 %), 2-Bromoisobutyryl 
bromide (BiBB) (97 %) and copper (I) chloride (CuCl) (99.9 %) were purchased from Alfa 
Aesar (U.K.). Isopropyl alcohol (iPA) (99 %), HPLC grade acetonitrile, sodium chloride 
(NaCl) (99.5 %), potassium hydroxide (KOH) (99%) and absolute ethanol (99 %) were 
purchased from Fisher Scientific (U.K.). Dimethylaminopyridine (DMAP) (97 %), fluorescein 
sodium salt (NaFl), Poloxamer 407, Poloxamer 188 and polyethylene glycol (PEG) 10 kDa 
were purchased from Sigma-Aldrich (U.K.). PEG 4 kDa (determined by 1H NMR to have Mn 
of 5 kDa)[14] was purchased from Fluka (U.K.). Aluminium oxide, neutral, Brockmann I, 
potassium phosphate monobasic monohydrate (99 %) and tenofovir disoproxil fumarate (98 
%) were purchased from Acros Organics (U.K.). Dialysis tubing with a molecular weight cut 
off (MWCO) of 3500 Da was purchased from Medicell Membrane Ltd (U.K.) and soaked in 
deionised H2O for at least 1 h before use. GPC EasiVial poly(methyl methacrylate) (PMMA) 
mixed standards were purchased from Agilent (U.K.). Dulbecco’s Modified Eagle’s Medium 
- high glucose with 4500 mg/L glucose, L-glutamine, sodium pyruvate and sodium bicarbonate 
(DMEM), Fetal Bovine Serum (FBS), L-Glutamine and Penicillin-Streptomycin (Pen-Strep) 
were purchased from Sigma-Aldrich (U.K.) and used as purchased. Immortalised human 
keratinocytes (HaCat) cells were purchased from ThermoFisher Scientific (U.K.). CytoTox-
ONE™ Homogeneous Membrane Integrity Assay (LDH) and CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (MTS) were purchased from Promega (U.K.) and used as per 
the manufacture’s instruction. Deionised H2O was used in all experiments. All reagents were 
used as supplied. 
 
2.2 Synthesis and characterisation of PDEA-b-PEG-b-PDEA copolymers 
Macroinitiators of 5 and 10 kDa PEG were synthesised and purified as described previously.[14] 




copolymers by atom transfer radical polymerisation (ATRP) are shown in SI (table S1). The 
PEG macro-initiator, ligand (Me6TREN) and DEA were placed in a round-bottom flask and 
dissolved in a 1:1 water:MeOH mixture. Copper(I) bromide was added to a separate flask. Both 
flasks were then sealed and degassed with nitrogen purge for 30 min. After degassing, the 
solution containing monomer, macroinitiator and ligand was transferred to the copper(I) 
bromide flask via a degassed syringe. The flask was then stirred at room temperature for 24 h. 
It has been reported that removal of copper by neutral alumina alone causes copper-related 
cytotoxicity, which can be eliminated by passage of sample through neutral alumina and 
dialysis.[16] Therefore, all copolymers were passed through alumina and dialysed for 
purification. Yields were > 86 % in all cases (SI, Table S1). These polymers are assigned 
identifiers based on the molecular weight in kDa of the constituent blocks, namely A10-B5-
A10, A20-B5-A20, A10-B10-A10, and A20-B10-A20. 
1H NMR was performed on an Oxford Instrument ECA600 600 MHz NMR spectrometer with 
Delta 4.3.6 software. All samples were measured in D2O. The Mn of triblock copolymers was 
calculated from 1H NMR. The ratio of the PEG peak integral (3.5 ppm) to that of the DEA 
proton peaks was used to determine Mn, given that the degree of polymerisation of PEG is 
known.[14] An Agilent 12600 Infinity II GPC equipped with a refractive index (RI) detector 
was used to characterise triblock copolymers, determining Đ and confirming monomodality. 
A Phenomenex Phenogel 10 µm 10E5 Å column was used with DMF with 0.1 % LiBr as an 
eluent, at a flow rate of 0.4 mL/min with the column and detector held at 30 °C. The GPC was 
calibrated with Agilent Easivial PMMA standards with Mn ranging from 370 to 364000 Da.  
 
2.3 Rheological evaluation of 20 % (w/v) solutions of PDEA-b-PEG-b-PDEA 
All rheology experiments were performed on a TA AR 1500 ex shear rheometer with a Peltier 
temperature control unit (±0.1 °C) using rheology advantage software and a 40 mm parallel 
plate. The gap was 650 µm. A solvent trap was used to prevent evaporation. All samples were 
prepared at the stated composition in aqueous solution and left overnight in the fridge before 
performing rheometry. All experiments were repeated 3 times. 
Oscillatory shear stress sweep (OSS) experiments were performed at 20 °C between 1 to 100 
Pa. The linear viscoelastic region (LVR) was identified as the region before the increase in 




determined to be the yield stress. Frequency sweeps were conducted between 0.1 and 10 Hz at 
a stress of 1 Pa.  
Temperature ramps were performed at 1 Pa of oscillatory stress and a frequency of 1 Hz, with 
an increase in temperature from 20 to 70 °C at a rate of 2 °C per minute. The Tgel was 
determined at the cross-over point between G′ and G″, a criterion widely used in the literature 
[17] and the gel “strength” was taken as the maximum value of G′ reached across the temperature 
range. Reversibility of this transition was explored by cycling the sample between 20 at 37 °C, 
holding for 60 s at each temperature with a pre-measurement equilibration time of 120 s 
whenever the temperature was altered. Time-dependency of gelation was determined by 
holding the sample at 20 °C for 60 s, then transitioning to 37 °C and keeping the temperature 
fixed for 240 s. A stress of 1 Pa and frequency of 1 Hz was used in these experiments. 
 
2.4 Small-Angle X-Ray Scattering (SAXS) measurements of copolymer solutions 
Samples of each copolymer were prepared at 5 wt% in deionised water. SAXS measurements 
were performed on a Nano-inXider SAXS/WAXS instrument (Xenocs, Sassenage, France) at 
the Materials Characterization Laboratory of the ISIS Neutron and Muon source (STFC, 
Rutherford Appleton Laboratory, Didcot, UK). The setup is equipped with a micro-focus 
sealed-tube Cu 30W/30 µm X-ray source (Cu K-α, λ = 1.54 Å) and two Dectris Pilatus 3 hybrid 
pixel detectors, covering scattering vector q-ranges (q = 4πsin(θ/2), where λ is the wavelength 
of the incident beam and θ is the scattering angle) of 0.0045 Å-1 to 0.37 Å-1 and 0.3 Å-1 to 4.1 
Å-1 for SAXS and WAXS, respectively. Scattering from the samples and water was collected 
in 1 mm glass thermalized capillaries at temperatures between 30 and 60 °C. Data reduction 
(azimuthal averaging, buffer subtraction, absolute scaling) was carried out using the Foxtrot 
software. SAXS data was fitted using Sasview 4.2.2 software.  
The scattering intensity I(q) can be written as follow: 
𝐼(𝑞) = 𝐴(𝑃(𝑞)𝐴𝑆(𝑞)𝐴) + 𝐵𝐾𝐺 
where, A is a scale factor, P(q) is the form factor of the scattering object, S(q)A is the 




If more than one scattering object is present or the object studied has a hierarchical structure 
that generates scattering at distinct length scales, the expression can be extended to include 
further terms. 
For this work, the polymer constructs, in general, give rise to two scattering components, one 
derived from their supramolecular structure and another from the polymeric chains. Therefore, 
the I(q) expression used was extended to: 
𝐼(𝑞) = 𝑆𝑐𝑎𝑙𝑒(𝐴(𝑃(𝑞)𝐴𝑆(𝑞)𝐴)) + 𝐵(𝑃(𝑞)𝑃𝐺𝐶) + 𝐵𝐾𝐺 
where, Scale, A and B are scale factors, , P(q)A is the form factor for the model A, S(q)A is the 
corresponding structure factor, P(q)PGC is the form factor model of polydisperse polymer coils, 
and BKG is the background. [18] 
The SAXS data were fitted as follow: A10-B5-A10, either as polymeric Gaussian coils[18] or 
with a cylinder model.[19,20] A10-B10-A10, either polymeric Gaussian coils,[18] ellipsoids[21,22] 
plus polymeric Gaussian coils[18] or sphere[23] model for form factor and hard spheres[24,25] for 
the structure factor as needed. A20-B5-A20, either polymeric Gaussian coils[18] or spheres[23] 
models. A20-B10-A20, either polymeric Gaussian coils,[18] ellipsoids[21,22] plus polymeric 
Gaussian[18] coils or sphere[23] models for form factors and hard spheres structure factor as 
needed.[25,26] 
  
2.5 Dynamic light scattering  
All dynamic light scattering (DLS) experiments were performed on a Malvern Zetasizer Nano 
ZS with a scattering angle of 173 °. 1 mg/mL polymer solutions were prepared in deionised 
water and stored in the fridge overnight before use.  Samples were then filtered through a 1 µm 
syringe filter and size measurements were taken at 50 °C as a comparator measurement above 
the thermal transition in all systems. A 5-minute equilibration period was used before each 
measurement, which was conducted in triplicate.  
 
2.6 Investigating the saturation solubility of progesterone and tenofovir disoproxil fumarate in 
A20-B10-A20 solution 
30 % A20-B10-A20 in 0.3 M NaCl was prepared and stored in the fridge overnight. Following 




tenofovir disoproxil fumarate (ca 5 mg) was added. The solutions were then placed in a water 
bath at 25 or 37 °C and allowed to stir for 24 h. If the resultant solution was clear, drug was 
again added and the sample left for 24 h in the water bath with constant stirring. This process 
was repeated until the solution remained turbid for 24 h. Excess drug was then removed by 
centrifugation (10 min at 14500 rpm) (“high speed microcentrifuge”, Four E’s) and the clear 
supernatant was analysed by HPLC using validated protocols described elsewhere.[14] Each 
experiment was performed in triplicate. 
 
2.7 Investigating the release of progesterone and tenofovir disoproxil fumarate in A20-B10-
A20 solution 
The release of progesterone and tenofovir disoproxil fumarate from the 30 % A20-B10-A20 
solution in 0.3 M NaCl was investigated using Franz diffusion cells (Soham Scientific, average 
bore size 174 mm2) equipped with a cellulose membrane (Medicell, MWCO 3.5 kDa) at both 
25 and 37 °C. The receiver fluid was 10 mL phosphate buffer saline (PBS). The release of 50 
µg/mL progesterone or tenofovir disoproxil fumarate in the polymer solution was investigated 
under sink conditions, by ensuring that drug in the receiver fluid could not exceed 10 % of the 
drugs’ saturation solubilities. The cells were placed into a water bath for 30 min prior to the 
experiment to reach the required temperature (25 or 37 °C). Cells were dosed with 200 µL of 
sample and the release of drug measured at regular intervals by sampling receiver fluid (1000 
or 200 µL for the progesterone and tenofovir disoproxil fumarate respectively). The receiver 
fluid was replaced with an equal volume of pre-warmed PBS. The samples were analysed by 
HPLC using established protocols.[14] The experiment was repeated 4 times. 
 
2.8 Culture of HaCaT cells 
The human keratinocyte (HaCaT) cell line was used between passage numbers 2 and 20 from 
purchase. Cells were maintained in T75cm2 cell culture flasks containing 15 mL Dulbecco’s 
Modified Eagle’s Medium (DMEM) with 10% v/v heat-inactivated foetal bovine serum (FBS) 
and supplemented with 100 IU/mL pencillin, 100 µg/mL streptomycin solution and 2 mM L-
glutamine. Cells were cultured in a humidified atmosphere at 37 °C with 5% v/v CO2. Cells 
were passaged using 5 mL 0.25% w/v trypsin-EDTA solution once weekly when 90% 




1 x 105 cells/well on 96 well tissue culture plates in 100 µL of complete cell culture medium 
and were cultured for 4 days prior to experimentation. 
 
2.9 Cytotoxicity testing of triblock copolymers on HaCat cells  
On the day of cytotoxicity assessment, cell culture medium was removed and replaced with 
100 µL cell culture medium containing 10 mg/mL copolymer. Controls of untreated cells and 
cells treated with 0.1 % v/v Triton-X 100 were included in each experiment. Cells were 
incubated at 37 °C in 5 % v/v CO2 for 2 h and assessed for viability. Four replicates of the 
condition were used for each sample. 
The CytoTox-ONETM Homogenenous Membrane Integrity assay kit was used to quantify the 
extracellular concentration of lactate dehydrogenase (LDH) which arises due to the presence 
of pores in the cell membrane, one indicator of cytotoxicity. After 2 h of polymer exposure, 50 
µL of cell supernatant was removed from each well and transferred to a black 96 well plate. To 
this, 50 uL of CytoTox-ONETM Reagent (1:1 ratio) was added and cells were incubated in the 
dark for 10 minutes at room temperature (~19 °C) before the addition of 25 µL of stop solution. 
Fluorescence was measured immediately using a Promega Glomax Multi Detection System 
fluorescence plate reader with excitation wavelength of 560 nm and an emission wavelength 
of 590 nm. The data was then expressed as a percent cytotoxicity compared to positive control 
cells dosed with 0.1 % v/v Triton-X 100 (Equation 1). 
 
Membrane Leakage (%) =  
(Dosed Cells − Background)
(Positive Control − Background)
 X 100               (Equation 1) 
 
The CellTiter96 Aqueous One Solution Cell Proliferation assay kit was used according to 
manufacturer’s instruction to assess mitochondrial activity of the cells. This is used in 
combination with LDH assay as an additional supporting measure of cell viability where pores 
may be present in the membrane, detectable by LDH assay, but of insufficient size to cause the 
membrane to be destroyed. After a 2 h exposure to polymers, 50 µL of supernatant was 
removed and 10 µL of CellTitre ONE Reagent was added to the remaining 50 µL cell sample 
(1:5 dilution). Samples were incubated for 2 h in a humidified incubator at 37 °C, 5% v/v CO2. 




(BMG Labtech). The data was expressed as percent metabolic activity compared to untreated 
cells in culture medium as a negative control (Equation 2).  
Metabolic Activity (%) =  
(Dosed Cells − Background)
(Untreated Cells − Background)
 X 100               (Equation 2) 
 
2.10 Ex vivo retention studies on porcine vaginal tissues 
Porcine vaginal tissues were received from P.C. Turner Abattoirs (Farnborough, UK) 
immediately after slaughter of the animals and were used for evaluating the mucoadhesive 
properties of the formulations using a previously described method.[27,28] The tissues were 
carefully excised to yield approximately 2×2 cm pieces, avoiding contact with the internal 
mucosa, which were then used in the experiments. The dissected vaginal tissue was mounted 
on a glass slide with mucosal side facing upward and pre-rinsed with 1 mL of vaginal fluid 
simulant (VFS; pH 4, preparation described in SI). Experiments were performed with the 
vaginal tissues maintained at 37 °C and 100 % relative humidity in an incubator. Aliquots (200 
μL) from 30 wt % PDEA-PEG-PDEA prepared in 0.3 M NaCl solution; 20 wt % Poloxamer 
407 and 20 wt% Poloxamer 188 solutions prepared in deionised water containing 0.2 mg/mL 
fluorescein sodium salt (NaFl) and a control of NaFl (0.2 mg/mL) solution were deposited onto 
a mucosal surface and rinsed with VFS at a constant flow rate of 0.3 mL/min using a syringe 
pump. Fluorescence images of a vaginal tissue were taken using Leica MZ10F stereo-
microscope (Leica Microsystems, UK) with Leica DFC3000G digital camera at 1.6× 
magnification with 10 ms exposure time (gain 1.0×), fitted with a GFP filter. The microscopy 
images were then analysed with ImageJ software by measuring the pixel intensity after each 
irrigation with VFS. The pixel intensity of the blank samples (vaginal mucosa without test 
material) was subtracted from each measurement and data were converted into values of 
intensity. All measurements were performed in triplicate. 
 
2.11 Investigating the stability of A20-B10-A20 under ambient, refrigerated and accelerated 
storage conditions. 
The stability of A20-B10-A20 copolymer was assessed over 12 weeks. Polymer solutions at 
30 % w/v in 0.3 M NaCl were prepared in HPLC vials sealed with parafilm and stored in the 




accelerated storage conditions, respectively. Each week three vials under each storage 
condition were lyophilised and the molecular weight determined by GPC.  
 
2.12 Statistical analysis 
Statistical analysis of data from mucoadhesion studies, i.e. mean values ± standard deviations, 
were calculated and assessed for significance using two-tailed Student’s t-test and a one-way 
analysis of variance (ANOVA) followed by Bonferroni post hoc test using GraphPad Prism 
software (version 7.0), where p < 0.05 was considered as statistically significant. 
 
3. Results and discussion 
PDEA-b-PEG-b-PDEA copolymers were synthesised by ATRP to give a series of samples with 
molecular weight (in kDa) of each block controlled at two values, namely: A10-B5-A10, A20-
B5-A20, A10-B10-A10, and A20-B10-A20. Polymer structure was confirmed by 1H NMR 
(Figure 1a), which was also used to determine the number average molecular weight of the 
blocks (Table S2, SI). GPC was used to determine the Đ, which was < 1.4 in all cases, and 
confirm the absence of residual PEG macroinitiator (Figure 1b,c). GPC also confirms the that 
PEG macroinitiator was not detectable in the product, with a shift of peak to lower elution 
times (and thus assumed greater molecular weight). Whilst PEG-b-PDEA copolymers have 
recently been reported in the literature,[13] to our knowledge this is the first reported synthesis 
of PDEA-b-PEG-b-PDEA. This is particularly significant where the ABA triblock copolymer 
architecture gives access to nanostructures unavailable to diblock geometries and is associated 
with an enhanced ability to form gel phases.[1] It was hypothesised that ABA triblock 
copolymers of this type should have the ability to act as “loops”, “bridges”, or “dangling 
chains” in micellar structures and form percolating gel phases in an analogous manner to 







Figure 1. a) 1H NMR spectra of DEA, PEG and an exemplar PDEA-b-PEG-b-PDEA 





The potential of the PDEA-b-PEG-b-PDEA copolymers to form thermoreversible gels in 
aqueous solution was then evaluated by small-amplitude oscillatory shear rheology as a 
function of temperature at a fixed concentration of 20 % (w/v). In these experiments G′ and G″ 
are measured as temperature changes at a fixed stress, within the linear viscoelastic region, and 
a fixed frequency. This ensures that any structures formed within the sample are not altered by 
high shear. All polymer architectures showed thermothickening from ca. 35-40 °C, increasing 
in viscosity with temperature above this point (Figure 2). The composition of the polymer 
induced notably different rheological behaviours in the systems. Samples with 5 kDa central 
PEG blocks increased in viscosity but exhibited predominantly liquid-like behaviour above the 
thermal transition, with G″ never exceeding G′. However, when 10 kDa PEG constitutes the 
“B” block of the ABA copolymer the materials exhibit a thermoresponsive gelation, with G′ 
exceeding G″, indicating a dominance of solid-like behaviour in the system when heated. The 
gelation of A10-B10-A10 and A20-B10-A20 occurred at 51.2 ± 1.8 and 45.9 ± 0.5 °C, 
respectively, indicating that the gelation process occurs at temperatures above the reported 
LCST of DEA homopolymer, ca 33 °C.[8] This deviation may be the result of several factors. 
Conjugation to hydrophilic species has been shown  to elevate LCST,[1]  and it is known that 
macromolecular transitions continue to evolve above the LCST.[30,31] For example, the degree 
of phase separation of PNIPAM chains occurs over a broad transition in PNIPAM-b-PEG-b-
PNIPAM copolymers.[30] Thus, nanostructures continue to evolve as heating continues above 
the LCST, rather than exhibiting a stepwise transition at this temperature. From the materials 
studied by rheology, A20-B10-A20 was identified as the most promising thermoreversible gel 






Figure 2. PDEA-b-PEG-b-PDEA copolymer solutions (20 % (w/v) studied by small-amplitude 
oscillatory shear rheology as a function of temperature, measured at a shear stress of 1 Pa and 
a frequency of 1 Hz. 
The size of assembled structures of PDEA-b-PEG-b-PDEA copolymers in dilute aqueous 
solutions (1 mg/mL) was probed by dynamic light scattering above the transition temperature 
(Figure 3) in order to extract differences between the constructs, which could give clues into 
the mechanisms of gelation in more concentrated systems. The constructs with the larger PEG 
block, A10-B10-A10 and A20-B10-A20, formed well-defined nanoparticles with 68 nm 
median hydrodynamic diameter and polydispersity indices of 0.22 and 0.08, respectively. The 
lower molecular weight 5 kDa PEG copolymers assembled into much larger structures than the 
10 kDa PEG constructs, with hydrodynamic diameters of 396 and 531 nm for A10-B5-A10 





Figure 3. Block copolymer aggregate size distributions in dilute aqueous solutions (1 mg/mL) 
at 50 °C as determined by dynamic light scattering. 
SAXS was employed to further probe the nanostructure of PDEA-b-PEG-b-PDEA copolymers 
as a function of temperature. Measurements were taken from 5 wt% solutions in H2O at 30, 37, 
40, 50, and 60 °C to span the range of temperatures covered by rheology and elucidate 
morphology above and below the transition temperature. All copolymers were investigated, 
however A20-B5-A20 visually showed evidence of phase separation at elevated temperatures 
– probably due to the large LCST blocks combined with the short hydrophilic PEG block – 
hence the data were not analysed. The scattering profiles of all copolymers showed clear 
structural transitions when warmed above 40 °C (Figure 4), in agreement with the rheology 
presented in Figure 2. The scattering from A10-B5-A10 system (figure 4a) was fitted with a 
polydisperse Gaussian coil (PGC) form factor at 30 and 37 °C, indicative of the system 
behaving as a disperse mixture of polymer chains in a theta solvent.[18] At 40 °C the system 
was fitted with a cylinder form factor (radius of 6.2 nm), the length of which was outside the 
length scale resolved by SAXS and is expected to be greater than ca. 80 nm based on the q 
range available. At this temperature a power law form factor (exponent 1.61) was added to the 
model to fit the high q region, which may be a contribution from polymer chains in a good 
solvent (exponent 1.66), possibly arising from PEG chains in the micellar corona.[32]. At 50 
and 60 °C, the data could be described by a cylinder form factor of radii 9.1 and 8.7 nm, 
respectively. These elongated structures are in agreement with the DLS data that detected very 
large aggregates. The construct with a larger PEG central block, A10-B10-A10 (Figure 4b) 




two form factors was again observed accounting for the presence of PGCs in addition to 
ellipsoidal objects with polar and equatorial radii of 20.5 and 10.2 nm, respectively. At 50 and 
60 °C, A10-B10-A10 data were best described by a spherical form factor with radii of 12.9 and 
13.7 nm, respectively, which also required a contribution from a hard sphere structure factor, 
accounting for inter-particle repulsions.[25,26] A20-B10-A20 copolymers, which bear larger side 
chains and the same size of PEG central block, followed a similar trend. At 30 °C the scattering 
data were fitted to a PGC form factor. At 37 °C, assembled structures with an elliptical shape, 
with polar and equatorial radii of 26.2 and 11.3 nm, respectively, were detected, in addition to 
polymer coils. The same combination of form factors was used at 40 °C, with the ellipsoids 
having polar and equatorial radii of 27.5 and 15.7 nm, respectively. At 50 and 60 °C, only the 
ellipsoid form factor was required to fit the data, giving polar and equatorial radii of 28.5 and 
19.1 nm, respectively, at 50 °C and of 27.8 and 19.3 nm at 60 °C, in broad agreement with the 
hydrodynamic diameter obtained from DLS. The ellipsoidal objects A20-B10-A20 also 
required the addition of a hard sphere structure factor to fit the data, which is a reasonable 
approximation for particle shapes that deviate from spheres.[25] Further detail about the models 





Figure 4. Small-Angle X-Ray Scattering profiles of (a) A10-B5-A10 (b) A10-B10-A10 and 
(c) A20-B10-A20 PDEA-b-PEG-b-PDEA copolymers at 5 wt % over the temperature range 30 
to 60°C. 
In summary, SAXS measurements indicate that the A10-B5-A10, A10-B10-A10 and A20-
B10-A20 constructs are present as polymer chains in solution at lower temperatures, which is 




structures, driven by the LCST transition and the association of the relatively hydrophobic 
PDEA chains, leading to an increase in visco-elasticity (Figure 2). Cylindrical structures are 
present in the A10-B5-A10 systems (Figure 5) above the transition temperature, which may be 
rationalised by the classical “molecular packing parameter” theory of surfactants that has been 
widely applied to self-assembled polymer structures.[33] In brief, the curvature of a micellar 
aggregate formed by polymeric amphiphiles is greatly dependent upon the area of the 
headgroup (in this case PEG) relative to the hydrophobic tail groups (PDEA above the LCST). 
When the relative area occupied by the headgroup is sufficiently small, the curvature necessary 
to form a sphere that minimises the interface cannot be achieved and cylindrical structures are 
formed, as seen in constructs with a low Mn PEG, such as A10-B5-A10, which are expected to 
be quite long as inferred from the DLS. Instead, the A10-B10-A10 constructs assembled into 
spheres above the LCST. In this case, the headgroup has a larger size and the packing parameter 
would allow sufficient curvature to thermodynamically favour a spherical shape. Above the 
LCST, the A20-B10-A20 copolymers assembled into ellipsoids with an aspect ratio of 
approximately 2:3. In this case, the relative size of the head-to-tail group is lower and again 
non-spherical structures are formed. Linking these findings to the rheology elucidates an 
important contribution of particle shape to viscoelasticity. The cylindrical A10-B5-A10 
nanostructures form viscous liquids dominated by the dissipative loss modulus (G″>G′). 
However, where spherical and ellipsoidal nanostructures are present, the systems form 
predominantly elastic gels (G′>G″) at higher concentrations. This may be rationalised by longer 
PEG chains in these systems the aggregates to be bridged by elastically active unimer chains. 
Whilst an attractive interaction associated with unimer bridges was not detected via SAXS in 
these dilute solutions, previous SANS studies at high concentrations support their presence.[34] 
Alternatively, the short chain length of PEG in the A10-B5-A10 and A20-B5-A20 systems may 
not allow bridge formation between aggregates. In this case, the increased viscosity in the A10-
B5-A10 and A20-B5-A20 constructs may be attributed to entanglements of elongated cylinders 
in a manner akin to the behaviour of wormlike micelles.[35] Interestingly, whilst PEG length is 
crucial to gelation, no upper limit to this has been identified in the literature, to our 
knowledge.[14,36–38] Future studies should expand this library to confirm optimal PEG block 
length at greater degrees of polymerisation. The A20-B5-A20 systems additionally showed 






Figure 5. Schematic representation of the self-assembled structures of PDEA-b-PEG-b-PDEA 
that form above the LCST. 
Cytotoxicity measurements were conducted on human keratinocyte (HaCaT) cells to guide the 
selection of candidate materials for healthcare applications (Figure 6). There was no evidence 
of cytotoxicity in either MTS assay, a measurement of mitochondrial activity, or LDH assay, 
which determines the porosity of the cell membrane when exposed to the A10-B5-A10, A10-
B10-A10, or A20-B10-A20 samples. Whilst the dosing interval for these materials was short 
(2 h), the measurements provide preliminary mitigation of safety risks until optimal materials 
can be tested under toxicological regimes recognised by regulatory bodies. This testing also 
provides reassurance that the materials can be used in cell-based applications such as 3D 





Figure 6. Evaluation of cytotoxicity by LDH (a) and MTS (b) assay showing membrane 
leakage of LDH and mitochondrial activity, respectively. Cells dosed with 10 mg/mL polymer 
solution for 2 h prior to evaluation. Positive controls were treated with 0.1 % v/v Triton-X 100. 
Insert on (a) is expanded to show near-zero values. * designates statistical significance from 
untreated cells (p < 0.05) by one-way ANOVA with Tukey post-hoc (GraphPad Prism, USA). 
Data is presented as mean ± standard deviation (n = 4).  
 
A20-B10-A20 was selected as the lead thermoreversible gelator for further optimisation due to 
its high gel strength and apparent cytocompatibility. The drawback of this material thus far is 
the transition temperature, with gelation not observed until 46 °C. Initially the lowering of this 
temperature (Tgel) was attempted by simply increasing the concentration of the material, where 
competition for solvent is believed to drive the LCST to lower temperatures in similar 
systems.[14,39,40] Aqueous solutions of A20-B10-A20 were prepared between 20 and 50 % w/v 
and evaluated by rheology (Figure S1), as previously described, and the thickening temperature 




Tgel decreased from ca 45 to 41 °C when the concentration was increased from 20 to 30 % 
(w/v), but plateaued above that concentration. Concurrently, G′max increased up to ca 5.8 kPa 
at 30 % (w/v), plateauing thereafter. The effect of sodium chloride on thermoreversible gel 
formation was then investigated to attempt to further reduce the LCST below physiological 
temperature (37 °C) (Figure 7b). A near-linear decrease in Tgel with sodium chloride 
concentration was observed. It is known that sodium chloride can alter the LCST of PNIPAM 
through the interaction of sodium cations with the oxygen atom in the amide group, which in 
turn reduces hydration.[41] It is reasonable to assume that this effect is also present in PDEA 
which is also a poly(N-alkyl acrylamide). The addition of 0.3 M sodium chloride to 30 % w/v 
A20-B10-A20 solutions gave a thermoreversible gel with Tgel occurring at 36 °C, therefore 
making it an attractive candidate for the design of in situ gelators intended to transition between 
room (ca 25 °C) and body (37 °C internally) temperature (Figure 6c). Hereon, this material is 




Figure 7. a) Effect of concentration on the transition temperature and maximum gel strength 
in aqueous solutions of A20-B10-A20. b) Effect of NaCl on these parameters at a set 
concentration of A20-B10-A20 (30 % (w/v)). c) Image of 30 % (w/v) A20-B10-A20 in 0.3 M 





A20-B10-A20 thermoreversible gel was subjected to rigorous rheological evaluation to probe 
its potential as a healthcare material. Oscillatory frequency sweeps (Figure 8a) revealed a low 
dependence of G′ and G″ on frequency, indicative of a rigid structure which did not undergo 
structural rearrangements over the test. Amplitude sweeps (Figure 8b) determined a linear 
viscoelastic region with a reduction in G′ indicative of the onset of yield occurring at 862 Pa, 
over three-fold higher than the “gold standard” thermoreversible gel of 20% (w/v) Poloxamer 
407 which was determined as 256 Pa.[14] This greater yield stress is valuable in applications 
where the materials are required to retain their shape under shear, such as in topical drug 
delivery and in maintaining form after bioprinting. The reversibility of the thermal gelation 
was confirmed by small amplitude oscillatory rheology switching between 25 and 37 °C 
(Figure 7c), confirming that the rheological behaviour was preserved after a heating-cooling 
cycle. Finally, the time required for gel formation was investigated by holding the sample at 
25 °C then ramping to 37 °C and maintaining the sample at that temperature under a small 
amplitude. The sample took 67 s to form a gel under these conditions which must be considered 





Figure 8. Rheological evaluation of the optimised A20-B10-A20 PDEA-b-PEG-b-PDEA 
copolymer as a 30 % (w/v) solution in 0.3 M NaCl. (a) Frequency and (b) amplitude sweeps at 
37 °C. (c) Reversibility of gelation determined by small-amplitude oscillatory rheology with 
switching between sol (20 °C) and gel (37 °C) states (please note there was a 120 s equilibration 
time at each temperature change during which data was not collected). (d) Time taken for 
gelation to occur determined by holding at 20 °C for 60 s, then switching to 37 °C. 
The stability of A20-B10-A20 was assessed in aqueous solution at 4, 25, or 40 °C, reflecting 
refrigerated storage, storage at room temperature, and an accelerated storage condition, 
respectively (Figure 9). Accelerated storage at 40 °C aimed to predict longer-term storage at 
room temperature. GPC analysis demonstrated that at 4 and 25 °C the reduction in number-
average molecular weight of A20-B10-A20 was not statistically significant, while at 40 °C 
there was a significant decrease only by week 12 (p < 0.05 by one-way ANOVA with Tukey 
post-hoc analysis (GraphPad Prism, USA)). GPC traces of A20-B10-A20 remained 
monomodal with no shoulder (Figure S2), suggesting a reduced likelihood that hydrolysis of 
the ester moieties between the A and B blocks is a major route of degradation under these 
conditions. Overall, the A20-B10-A20 copolymer appears stable at and below room 
temperature in solution for the 12-week study period, supporting its stability during use in 
pharmaceuticals or cell culture. 
 
Figure 9. Number-average molecular weight (Mn) of A20-B10-A20 during storage at 4, 25 and 






The high-performance of the A20-B10-A20 thermoreversible gel makes it an attractive 
candidate for topical drug delivery to the vagina, where poor retention at this site due to shear 
forces reduces the efficacy of many semi-solids.[42] Thus, drugs applicable to vaginal drug 
delivery were incorporated into the thermoreversible gels to evaluate performance in topical 
drug delivery. Two drugs were investigated for inclusion into the thermoreversible gel, namely 
progesterone and tenofovir disoproxil fumarate, which have been applied intravaginally for 
indications including luteal phase support and HIV pre-exposure prophylaxis, 
respectively.[43,44] Progesterone (clogP = 3.87) is considered to be hydrophobic while tenofovir 
disoproxil fumarate (clogP = 1.25) is more hydrophilic with saturation solubilities in PBS at 
25 °C of 9 ± 1 and 7065 ± 412 µg/mL, respectively, and in PBS at 37 °C of 11 ± 1 and 12269 
± 393 µg/mL, respectively. It was found that the solubility of progesterone was greatly 
enhanced by inclusion in the A20-B10-A20 thermoreversible gel, particularly above Tgel, with 
progesterone saturation solubilities at 25 and 37 °C of 156 ± 6 and 324 ± 8 µg/mL, respectively, 
equivalent to a 17- and 29-fold increase in solubility. This is attributed to the formation of 
relatively hydrophobic PDEA domains in the material, even below the LCST. The saturation 
solubility of tenofovir disoproxil fumarate was adversely affected in the thermoreversible gels, 
having values at 25 and 37 °C of 2582 ± 280 and 324 ± 8 µg/mL, respectively, equivalent to a 
3- and 2-fold decrease, respectively. This decrease in solubility is partly explained by the 
reduced volume fraction of water but will also be a result of high solute concentration resulting 
in competition for hydration. 
 
The release of progesterone or tenofovir disoproxil fumarate (50 µg/mL) from the A20-B10-
A20 thermoreversible gel across cellulose membrane was investigated at both 25 and 37 °C 
(Figure 10). Progesterone release (Figure 9a) from the A20-B10-A20 thermoreversible gel at 
25 °C followed Higuchi kinetics and 100 % of the drug was released after 32 h. The Higuchi 
model was applied to this release data as it is suitable for describing the release of both 
sparingly and abundantly soluble therapeutics from planar dosage forms.[45] This model is 
based on a linear fit to the fractional drug release with the square-root of time.[46] Increasing 
the temperature to 37 °C retarded the release of progesterone significantly, with 100 % drug 
liberated only after 144 h. This retardation of release at 37 °C is attributed to the formation of 
the gel phase, which provides microphase separated PDEA domains of relative hydrophobicity 
in which drug solubilisation may occur, disfavouring release. Additionally, increased tortuosity 




phase will contribute to retardation by ultimately increasing distance over which diffusion must 
occur. The progesterone release profile at 37 °C did not follow the Higuchi model, but its 
kinetics were linear after a 24 h lag period (R2 > 0.99), which is highly attractive for controlled 
drug delivery releasing near-identical doses each day of use. The mechanisms for this zero-
order behaviour can be rationalised by analogy to biphasic hydrogels containing hydrophilic 
polymer chains modified to possess hydrophobic moieties, as described by Varelas and co-
workers.[47] In these systems where swollen hydrogels contain hydrophobic microdomains, 
hydrophobic drugs partition preferentially into the microdomains which act as reservoirs. On 
exposure to excess water of low solute concentration, the drug is released from the gel by 
diffusion through the bulk hydrogel phase, which is then restored to the bulk from the 
microdomain reservoirs. If the flux achieved by these two processes are comparable, the 
concentration of drug in the bulk hydrogel remains steady and the driving force for diffusion 
is at a pseudo-steady state and zero order release is possible. The release of tenofovir disoproxil 
fumarate from the thermoreversible gel was more rapid, with ca. 65 % drug release occurring 
after 8 h, and was unaffected by temperature. This has been reported for PNIPAM-b-PEG-b-
PNIPAM gels, where it was hypothesised that the effect of increased tortuosity above Tgel is 
counteracted by increased thermal energy favouring diffusion across the membrane.[14] 
Furthermore, the relatively hydrophilic tenofovir is not expected to partition favourably into 
the phase separated PDEA domains, counteracting any reservoir effect. 
 
Figure 10. Release of progesterone (a) and tenofovir disoproxil fumarate (b) from A20-B10-





The potential of the A20-B10-A20 thermoreversible gels in vaginal drug delivery was further 
probed by assessing mucoadhesion using an established flow-through method.28,[48] In brief, 
fluorescein-doped samples were applied to the surface of ex vivo porcine vaginal mucosa and 
allowed to equilibrate at 37 °C, mimicking internal body temperature.[42] Simulated vaginal 
fluid was then washed over the surface of the mucosa and the presence of sample determined 
by fluorescence microscopy (Figure 11a). This retention can be quantified by the measurement 
of image pixel intensity with time (Figure 11b) to give a percentage of the fluorescence at time 
zero. The A20-B10-A20 thermoreversible gel was compared against Poloxamer 407 (20 wt%) 
as a widely used thermoreversible gel,[12,49,50] Poloxamer 188 (20 wt%) as a non-gel-forming 
polymer control, and fluorescein solution as a negative non-mucoadhesive control. The A20-
B10-A20 thermoreversible gel could match the behaviour of Poloxamer 407 gel, giving non-
significant differences in retention at the experiment end whilst having the benefit of Tgel closer 
to body temperature. The A20-B10-A20 thermoreversible gel outperformed the negative 
control and the Poloxamer 188 control, showing discrimination between mucoadhesive and 
non-mucoadhesive samples in the experiment. Future tuning of A20-B10-A20 construct could 
lead to a material that outperforms Poloxamer 407, either by further chemical modification of 
the copolymer to enhance covalent mucosa-polymer interactions (such as by thiol or maleimide 





Figure 11. a) Selected fluorescence images showing retention of fluorescein sodium salt 
(NaFl), Poloxamer 188, PDEA-PEG-PDEA and Poloxamer 407 on freshly dissected porcine 
vaginal tissue washed with different volumes of VFS solution (flow rate 0.3 mL/min). 
Fluorescence microscope parameters: exposure time – 10 ms; gain – 1x, magnification – 16x. 
Scale bars are 2 mm. b) Percentage retention of fluorescein sodium salt (NaFl), Poloxamer 188 
, Poloxamer 407 and PDEA-PEG-PDEA on freshly exiced porcine vaginal tissue after 
irrigating with different volumes of VFS solution (flow rate 0.3 mL/min). Data are expressed 
as mean ± standard deviation (n = 3). Statistically significant differences are given as: * = p < 





4. Conclusions  
Triblock copolymers with the structure PDEA-b-PEG-b-PDEA exhibit a temperature-
dependent rheological response in aqueous solution, where heating above ca 35 °C induced an 
increase in viscosity. When heated, copolymer solutions with a 5 kDa central PEG blocks 
formed a viscous phase with dominance of a liquid-like behaviour (G″>G′), whereas constructs 
with 10 kDa PEG blocks formed gel phases with a predominantly solid-like behaviour (G′>G″). 
SAXS revealed that A10-B5-A10 copolymers (5 kDa central PEG) formed cylindrical 
nanostructures above the transition temperature, whereas A10-B10-A10 and A20-B10-A20 (10 
kDa central PEG) formed spherical and elliptical aggregates, respectively; it is hypothesized 
that these aggregates are subsequently connected by long PEG chains forming bridges to form 
a percolating gel network. Combining rheology with cell culture studies led to the selection of 
A20-B10-A20 as the most promising thermoreversible gel for healthcare applications. Control 
of A20-B10-A20 concentration (30 % w/v) and ionic strength (0.3 M NaCl) allowed the 
gelation temperature to be manipulated to below 37 °C, enabling in situ gelation upon contact 
with the body’s internal temperature, or warming during cell culture, for instance. This 
optimised material was highly-functional for topical drug delivery, enabling solubilisation of 
poorly water-soluble progesterone and releasing the drug over 6 days, as well as matching the 
performance of Poloxamer 407 in mucoadhesion studies.  
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Preparation of vaginal fluid simulant 
Vaginal fluid simulant (VFS) was prepared according to the previously reported protocol 
[Derek H. Owen and David F. Katz. A vaginal fluid simulant. Contraception 1999, 59, 91-
95]. The recipe for 1 L preparation of vaginal fluid simulant (VFS) in deionised water: 
Compound name Amount (g) 
Sodium chloride (NaCl) 3.51 g (0.060 mol) 
Potassium chloride (KOH) 1.40 g (0.025 mol) 
Calcium chloride (Ca(OH)2) 0.222 g (0.003 mol) 
Bovine serum albumin 0.018 g 
Lactic acid 2.0 g (0.022 mol) 
Acetic acid 1.0 g (0.011 mol) 
Glycerol 0.16 g (0.002 mol) 
Urea 0.40 g (0.007 mol) 
Glucose 5.0 g (0.028 mol) 
 
































































































Table S2. Molecular weight and polydispersity of PDEA-b-PEG-b-PDEA copolymers. 









A10-B5-A10 31 13 1.40 
A20-B5-A20 47 21 1.35 
A10-B10-A10 36 13 1.18 






Table S3. Fitting parameters of SAXS data for the A10-B5-A10 copolymer. Cyl = Cylinder 
form factor, PGC = polydisperse Gaussian coil form factor 
 Temp (°C): 30 37 40 50 60 
Model PGC PGC Cyl+PL Cyl Cyl 
Cylinder length (Å)     1000 1000 1000 
Radius of the cross-section (Å)     62 91 87 
SLDscatterer (10
-6 Å-2)     9.40 9.40 9.40 
SLDsolvent (10
-6 Å-2)     9.20 9.20 9.20 
I0 (cm
-1) 0.0062 0.0108       
Radius of Gyration (Å) 48.55 98.34       
Polymer polydispersity 2.00 2.00       
Radius polydispersity     0.20 0.20 0.20 
Power Law exponent     1.60     
 
 
Table S4. Fitting parameters of SAXS data for the A10-B10-A10 copolymer. Sp = Sphere form 
factor, Ep = Elliptical form factor, HSp = hard sphere structure factor. 
 Temp (°C): 30 37 40 50 60 
Model PGC PGC Ep+PGC SpHSp SpHSp 
Polar radius (Å)     205 129 137 
Equatorial radius (Å)     102     
SLDscatterer (10
-6 Å-2)     9.2 9.2 9.2 
SLDsolvent (10
-6 Å-2)     9.4 9.4 9.4 
Effective radius (Å)       216 211 
Correlated volume fraction       0.12 0.11 
I0 (cm
-1) 0.0065 0.0089 0.0080     
Radius of Gyration (Å) 44.49 70.63 73.38     
Polymer polydispersity 2.00 2.00 2.00     
Radius polydispersity      0.20 0.20 
Radius polydispersity      0.20 0.20 











Table S5. Fitting parameters of SAXS data for the A20-B10-A20 copolymer. HSp = hard 
sphere structure factor, PGC = polydisperse Gaussian coil form factor. 
 Temp (°C): 30 37 40 50 60 
Model PGC Ep+PGC EpHSp+PGC EpHSp EpHSp 
Polar radius   262 275 285 278 
Equatorial radius   113 157 191 193 
SLDscatterer (10
-6 Å-2)   9.2 9.2 9.2 9.2 
SLDsolvent (10
-6 Å-2)   9.4 9.4 9.4 9.4 
Effective radius (Å)     264 286 282 
Correlated volume fraction     0.07 0.11 0.09 
I0 (cm
-1) 0.0073 0.074 0.0053     
Radius of Gyration (Å) 63.10 40.00 45.27     
Polymer polydispersity 2.00 2.00 2.00     
Polar radius polydispersity     0.20 0.05 0.05 







Figure S1. Rheometric temperature ramps of 25-50 % (w/v) aqueous solutions of A20-B10-
A20, with G′ shown in red and G″ in black. Rheometry was conducted at 1 Hz and 1 Pa in 





Figure S2. GPC traces of A20-B10-A20 after storage in solution at week 0 (blue) and week 12 
at 4 (red), 25 (grey) and 40 °C (yellow). 
 
